Savaria Co. (TSE:SIS - Get Free Report) Director Jean-Louis Chapdelaine sold 14,898 shares of Savaria stock in a transaction dated Friday, August 7th. The shares were sold at an average price of C$30.24, for a total value of C$450,515.52. Following the completion of the sale, the director owned 100,000 shares of the company's stock, valued at C$3,024,000. The trade was a 12.97% decrease in their ownership of the stock.
Jean-Louis Chapdelaine also recently made the following trade(s):
- On Friday, August 7th, Jean-Louis Chapdelaine sold 10,917 shares of Savaria stock. The shares were sold at an average price of C$30.24, for a total transaction of C$330,130.08.
- On Friday, August 7th, Jean-Louis Chapdelaine sold 13,020 shares of Savaria stock. The stock was sold at an average price of C$30.24, for a total transaction of C$393,724.80.
- On Friday, August 7th, Jean-Louis Chapdelaine sold 10,053 shares of Savaria stock. The stock was sold at an average price of C$30.24, for a total value of C$304,002.72.
- On Friday, August 7th, Jean-Louis Chapdelaine sold 10,623 shares of Savaria stock. The shares were sold at an average price of C$30.24, for a total value of C$321,239.52.
- On Tuesday, May 12th, Jean-Louis Chapdelaine sold 25,000 shares of Savaria stock. The shares were sold at an average price of C$27.73, for a total value of C$693,250.00.
Savaria Stock Down 1.4%
Shares of SIS traded down C$0.44 during trading hours on Friday, hitting C$30.40. The company had a trading volume of 354,038 shares, compared to its average volume of 180,113. The company has a market capitalization of C$2.19 billion, a PE ratio of 27.64, a price-to-earnings-growth ratio of 42.72 and a beta of 1.04. The company has a current ratio of 1.71, a quick ratio of 0.91 and a debt-to-equity ratio of 31.42. Savaria Co. has a one year low of C$20.10 and a one year high of C$31.95. The company's fifty day moving average price is C$29.77 and its two-hundred day moving average price is C$27.84.
Savaria (TSE:SIS - Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported C$0.35 EPS for the quarter. The business had revenue of C$245.78 million during the quarter. Savaria had a net margin of 8.50% and a return on equity of 12.41%. As a group, equities analysts forecast that Savaria Co. will post 1.2048518 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Several brokerages have weighed in on SIS. TD raised their target price on shares of Savaria from C$35.00 to C$37.00 and gave the company a "buy" rating in a research note on Friday. Desjardins upped their price target on Savaria from C$36.00 to C$39.00 and gave the stock a "buy" rating in a research report on Friday. TD Securities upgraded Savaria to a "strong-buy" rating in a report on Friday, July 24th. National Bank Financial boosted their target price on Savaria from C$30.50 to C$37.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 22nd. Finally, Scotia upped their target price on Savaria from C$30.00 to C$33.00 and gave the company a "sector outperform" rating in a research report on Thursday, April 16th. One analyst has rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Buy" and an average target price of C$34.33.
Read Our Latest Stock Report on Savaria
About Savaria
(
Get Free Report)
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Savaria, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Savaria wasn't on the list.
While Savaria currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
